Morning Market Losers

shares declined 43.67 percent to $3.56. Zosano Pharma reported that it has discontinued the development of its Daily ZP-PTH treatment for severe osteoporosis and will resume development of its Weekly ZP-PTH product. The company also decided to terminate the collaboration with

.

shares dipped 34.82 percent to $22.87 following an update on ETC-1002 global Phase 3 strategy and analyst price target cuts.

dropped 31.47 percent to $9.95. OvaScience reported that it does not expect to meet the 2015 goal of 1,000 AUGMENTSM treatment cycles.

shrank 19.07 percent to $33.18 after the company lowered its FY16 earnings forecast.

fell 14.87 percent to $22.32. Comtech Telecomm reported Q4 sales of $77.5 million and GAAP earnings of $0.34 per share.

shares declined 14.03 percent to $1.90 after the company reported positive results of an independent ProBiora3 study.

shares fell 11.90 percent to $41.01 after rising 4.37 percent on Monday.

slipped 2.92 percent to $1.66 after the company priced 7.6 million shares at $1.57 per share.